Rexahn Pharmaceuticals Inc (NYSE American:RNN)

2.17
Delayed Data
As of May 22
 -0.11 / -4.82%
Today’s Change
1.42
Today|||52-Week Range
4.37
+7.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization11.0K11.0K11.4K14.6K
 
 
 
 
 
 
Operating ExpensesGross Income-11.0K-11.0K-11.4K-14.6K
 
 
 
 
 
General Expenses4.3M4.2M4.9M5.9M
 
 
 
 
 
Research And Development2.5M2.6M3.3M4.1M
 
 
 
 
 
Total Operating Expenses4.3M4.2M4.9M5.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-4.2M-4.9M-5.9M
 
 
 
 
 
Extraordinary Credit5.5M3.1M1.5M3.4M
 
 
 
 
 
Other Expenses-333.1K0.00-219.6K368.8K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income947.1K-1.0M-3.6M-2.1M
 
 
 
 
 
Net Income947.1K-1.0M-3.6M-2.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.0M28.5M29.9M31.7M
 
 
 
 
 
Shares To Calculate EPS Diluted28.3M28.5M29.9M31.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.03-$0.04-$0.12-$0.07
 
 
 
 
 
EPS Diluted$0.03-$0.04-$0.12-$0.07